2.2. Analysis.
Comparison 2: Ivermectin compared to placebo or standard of care for people with mild COVID‐19 treated in the outpatient setting, Outcome 2: Worsening of clinical status – need for invasive mechanical ventilation up to 14 days (primary analysis)